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Abstract
The Polo-Like Kinase 1 (PLK1) acts as a central regulator of mitosis and is over-expressed in a wide range of human tumours
where high levels of expression correlate with a poor prognosis. PLK1 comprises two structural elements, a kinase domain
and a polo-box domain (PBD). The PBD binds phosphorylated substrates to control substrate phosphorylation by the kinase
domain. Although the PBD preferentially binds to phosphopeptides, it has a relatively broad sequence specificity in
comparison with other phosphopeptide binding domains. We analysed the molecular determinants of recognition by
performing molecular dynamics simulations of the PBD with one of its natural substrates, CDC25c. Predicted binding free
energies were calculated using a molecular mechanics, Poisson-Boltzmann surface area approach. We calculated the per-
residue contributions to the binding free energy change, showing that the phosphothreonine residue and the mainchain
account for the vast majority of the interaction energy. This explains the very broad sequence specificity with respect to
other sidechain residues. Finally, we considered the key role of bridging water molecules at the binding interface. We
employed inhomogeneous fluid solvation theory to consider the free energy of water molecules on the protein surface with
respect to bulk water molecules. Such an analysis highlights binding hotspots created by elimination of water molecules
from hydrophobic surfaces. It also predicts that a number of water molecules are stabilized by the presence of the charged
phosphate group, and that this will have a significant effect on the binding affinity. Our findings suggest a molecular
rationale for the promiscuous binding of the PBD and highlight a role for bridging water molecules at the interface. We
expect that this method of analysis will be very useful for probing other protein surfaces to identify binding hotspots for
natural binding partners and small molecule inhibitors.
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Introduction
Mitotic cell division involves a tightly orchestrated series of
events that precisely segregate an equal complement of chromo-
somes to two daughter cells. Abnormalities in mitosis generate
aneuploid cells containing an unequal distribution of chromo-
somes, which may represent a starting point for the genesis of
cancer. The polo-like kinase 1 (PLK1) is an important of mitosis,
working at different steps to facilitate mitotic entry, progression
through the stages of chromosome segregation, and finally, mitotic
exit [1–3]. To do so, PLK1 must phosphorylate a wide range of
protein substrates, yet operate in a manner that is tightly
controlled in space and time [4]. How these conflicting
requirements for PLK1 activity are fulfilled during mitosis remains
unclear. However, recent findings suggest that PLK1 activity is
frequently mis-regulated in human cancers. Thus, PLK1 is
overexpressed in a wide range of human tumours, with high
expression levels often correlating with poor prognosis [5].
PLK1 consists of two distinct functional domains: an N-terminal
kinase domain responsible for catalytic activity, and a C-terminal
polo-box domain (PBD), which binds PLK1 target proteins. A flexible
linker of approximately 50 amino acids joins these two domains
together. The kinase activity leads to the phosphorylation and
activation of a number of key mitotic proteins, notably Wee1,
CDC25c, BubR1 and CyclinB1 [6–8]. Studies have established that
the PBD is a phosphopeptide binding domain which binds to the
consensus phosphopeptide sequence [Pro/Phe]-[W/Pro]-[W]-[Thr/
Gln/His/Met]-Ser-[pThr/pSer]-[Pro/W], where W represents a
hydrophobic residue [9–10]. Elia et al also identified a high-affinity
synthetic phosphopeptide for PLK1, which has the sequence
PMQSpTPL. However, at the majority of positions in this sequence,
there is no particular preference for specific residues. This relatively
broad specificity with respect to phosphopeptide binding allows
PLK1 to bind a large set of phosphorylation-primed target proteins.
A comprehensive proteomic analysis identified 622 potential binding
partners of PLK1 [11] and at least 17 of these have been confirmed as
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binding partners [1]. Structural elucidation of the PBD has shown
that it adopts a unique fold which forms a narrow groove into which
phosphopeptides bind [9,12–14]. The structure of the PBD of PLK1
from the Protein Data Bank (PDB) with PDBID 3BZI [10] can be
seen in Figure 1. The exact mechanism for the function of the PBD
has not been definitively determined, but the evidence suggests that it
provides a scaffold where proteins can bind after they have been
phosphorylated at other sites by priming enzymes like cyclin-
dependent kinases [10]. It has been suggested that these bound
proteins may then act as substrates for the kinase activity of PLK1 or
may cause a conformational change allowing other substrates to bind
to the kinase domain. Such regulatory mechanisms are found in other
kinases, where interaction domains such as FHA, SH2, WW and 14-
3-3 act as molecular switchboards, allowing interactions to occur with
specific partners [15]. The available crystal structures identify
Trp414, His538 and Lys540 as the key residues for phosphopeptide
binding. The importance of these residues has been confirmed by
cell-based experiments where their mutation abolishes PBD binding
capacity [10,16].
Considering the phosphopeptide sequence, initial work high-
lighted a striking selectivity for serine at the 21 position and slight
selectivity for proline at the +1 position, but very little selectivity at
any other position [9]. This lack of selectivity suggests that the
phosphopeptide recognition site is highly promiscuous. Whilst this
is unusual, it is consistent with PLK1’s multiple functions
throughout mitosis. However, the existence of such a large
number of PBD-interacting phosphopeptides demands a molecu-
lar explanation. One striking feature of the PBD crystal structures
generated to date is the nature of the interfacial contacts made
between the PBD and bound phosphopeptide. Yun et al have
recently crystallised a variety of short phosphopeptides complexes
with the PBD [14]. Peptides as small as HSpTP and LHSpT were
shown to bind to the PBD. This suggests that a large proportion of
the binding energy is contributed by the core SpT motif. This
suggestion is supported by analysis of the two complexes of the
PBD with PMQSpTPL from PDBID 1UMW and LLCSpTPN
from PDBID 3BZI. Both Gln and Cys residues form intermolec-
ular interactions with the PBD at the 22 position and both Leu
and Gln residues form intermolecular interactions at the +2
position [14]. The ability of very different residues to make
contacts further supports the idea that the core SpT motif is the
main determinant of binding. A second striking feature of the
crystal structures of the PBD-phosphopeptide complexes is the
large fraction of interactions between the phosphopeptide and the
protein that are bridged by water molecules. For example, in
Author Summary
Cell division is a key biological process and imperfections
in the process can lead to diseases like cancer. Polo-Like
Kinase 1 (PLK1) is a protein kinase enzyme that controls
cell division by interacting with many other proteins.
Malfunction of PLK1 has been implicated in cancer. To
understand how PLK1 interacts with so many other
proteins, we created a three-dimensional model of PLK1
and simulated its dynamic nature. Analysis of the
components of the binding affinity provided insight into
how the binding specificity is achieved. We also employed
a method of analysis that locates regions of the protein
surface that are particularly important in controlling
binding affinity. Our results not only provide a valuable
tool that can be generally applied to analyzing the binding
between protein surfaces, but also provide insights into
how PLK1 works to control cell division by binding to
specific partners. In the future, these analyses could help
to design drugs that block the interaction between PLK1
and its partners to block cell division for the treatment of
diseases like cancer.
Figure 1. The PBD of PLK1 crystallised with the CDC25c phosphopeptide. The crystal structure of the PBD of PLK1 in complex with the
CDC25c phosphopeptide LLCSpTPN from PDB ID 3BZI. (a) The protein represented as a ribbon diagram with the phosphopeptide displayed by atom-
colored space filling (b) The binding site shown in more detail. The phosphopeptide is displayed as atom colored ball and sticks, interfacial water
molecules are displayed in atom-colored CPK and residues Trp414 and Lys540 are named in black and displayed in atom-colored CPK. Key hydrogen
bonds are displayed as yellow lines.
doi:10.1371/journal.pcbi.1000880.g001
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PDBID 3BZI, there are 18 hydrogen bonding interactions
between the PBD and the CDC25c phosphopeptide, 9 of which
are bridged through water molecules. The number of interactions
bridged by water molecules is significantly greater than in other
phosphopeptide-binding proteins. For example, the phosphopep-
tide bound with the 14-3-3 protein from PDBID 1YWT [17]
makes 13 hydrogen bonding interactions at the interface but only
1 through a water molecule. In other examples, the phosphopep-
tide bound with the SRC-SH2 domain from PDBID 2PIE [18]
makes 16 hydrogen bonding interactions at the interface with only
4 through water molecules, and the phosphopeptide bound with
the Rad53p-FHA1 domain from PDBID 1G6G makes 15
hydrogen bonding interactions, none of which are mediated by
water molecules [19]. Therefore, bridging water molecules appear
to play a specific and important role in PBD-phosphopeptide
interactions.
The overall aim of the study was to explore the energetics and
dynamics of PLK1 PBD interactions and probe the nature of the
water molecules at the interface and how they affect binding. To
assess the determinants of binding and gauge the role of water
molecules in phosphopeptides binding to the PBD of PLK1, we
performed molecular dynamics (MD) simulations to study the
motion of atoms within the complexes. Crucially, this approach
captures the dynamic aspects of interactions that are ignored by
calculations performed on static systems [20]. It has also proved to
be more accurate than other methods for estimating binding free
energies [21]. The strengths of the interactions were estimated
using a molecular mechanics, Poisson-Boltzmann surface area
(MM-PBSA) approach [22–23]. This approach has been used in
the past for analysing the role of water molecules at protein-
protein interfaces [24]. The determinants of affinity and the
importance of water molecules at peptide binding interfaces have
also been explored using MD simulations, for the SRC SH2
domain [25] and at a small molecule binding interface for the
GRB2 SH2 domain [26]. In addition, we assessed binding energy
contributions from discrete residues within the phosphopeptide
chain in an attempt to provide an energetic framework which
explains the ability of PBD to accommodate such a wide range of
phosphopeptide ligands and, therefore, to function with such a
diverse range of targets throughout mitosis. Lastly, we employed
inhomogeneous fluid solvation theory to predict the enthalpy and
entropy of hydration sites on the surface of the apo protein and the
phosphopeptide complex in order to understand the importance of
water molecules in mediating the intermolecular interactions. This
understanding allows us to elucidate the mechanisms controlling
affinity and specificity in this system, providing biologically
relevant information and facilitating drug development efforts.
Materials and Methods
We performed MD simulations of the PBD in the phosphopep-
tide-bound complex, the peptide-bound complex and the apo
state. The phosphopeptide-bound structure in complex with the
CDC25c sequence LLCSpTPN was taken from PDB ID 3BZI at
2.10 A˚ resolution [10]. The crystal structure is taken from a
protein construct containing PLK1 residues 367–603, of which
residues 371–593 have assigned density. This version of the PBD is
more amenable for crystallisation and still retains the crucial
features which are responsible for substrate binding and specificity
[10]. We did not use the peptide-bound structure in complex with
the CDC25c sequence LLCSTPN from PDB ID 2OJX as it has a
resolution of 2.85 A˚ and residues 489–506 could not be assigned
from the density. Instead, we generated the peptide-bound
complex by deletion of the phosphate group from the phospho-
peptide-bound complex from PDBID 3BZI. The apo state was
created by deletion of the entire phosphopeptide from the
phosphopeptide-bound complex. We consider this technique to
be reasonable, as the crystal structures of the apo states from
PDBID 2OGQ [13] and PDBID 3HIH [14] show no significant
deviation from the holo states.
Structure Preparation
The protein structures were initially prepared as follows. Atom
coordinates for the protein, the phosphopeptide, and the water
molecules were taken from the PDB. The hydrogen-atom positions
for the protein and the water molecules were then built using the
HBUILD facility of the CHARMM (version 34b1) program [27]
with the CHARMM22 energy function [28]. Histidine residues
were checked for protonation state manually. His382 was assigned
as epsilon protonated and His 538 was assigned as positively
charged for the phosphopeptide complex and as delta protonated
for the peptide complex and the apo protein. All remaining
histidines were assigned as delta protonated. The residues lysine,
arginine, aspartate, glutamate, cysteine, and tyrosine were also
analyzed to check their protonation state. There was no evidence
of any unusual protonation states and thus all lysine and arginine
residues were assigned as positively charged, all aspartate and
glutamate residues were assigned as negatively charged, and all
cysteine and tyrosine residues were assigned as neutral. The
atomic charges of the standard residues were assigned from the
CHARMM22 forcefield. The phosphate moiety from the
phosphothreonine residue was assigned to be doubly deproto-
nated, as this is likely to be the dominant species at physiological
pH of around 7.0, particularly when in close proximity to the
positively charged binding site. The atomic charges of the
dianionic phosphothreonine residues were assigned from the
CHARMM27 forcefield, which is based on the charges of
methylphosphate [29].
Molecular Dynamics
We performed MD simulations at 300 K on the apo state, the
peptide complex and the phosphopeptide complex to investigate
the dynamic nature of the interactions between the protein, the
peptide or phosphopeptide and the water molecules. All three
structures were prepared separately using the process schemati-
cally represented in Figure 2. In the first stage of preparation, the
system was solvated with TIP3P water molecules [30] around the
binding site. All the water molecules observed in the crystal
structure were retained before solvating with the sphere of water
molecules. Any water molecule overlapping with the protein, the
crystal structure water molecules, the peptide or the phosphopep-
tide were removed. The solvent sphere of radius 20 s was centred
at the coordinates of the heavy atom centroid of the CDC25c
phosphopeptide from 3BZI. The sphere completely enclosed the
peptide and the binding site residues, extending at least 5.0 A˚ from
the peptide or phosphopeptide. This assembly was partitioned into
a 16 A˚/20 A˚ reaction region/buffer region for stochastic bound-
ary MD [27]. The solvent was then minimized by steepest descent
(SD) for 5000 steps and then subjected to a 5 ps Langevin
dynamics equilibration period at 300 K, during which the solute
atom positions were fixed. The binding site was then repacked
with TIP3P water molecules to fill any gaps. Any water molecule
overlapping with the protein, the existing water molecules, the
peptide or the phosphopeptide was removed. The solvent was
again minimized by SD for 5000 steps and then subjected to
another 5ps Langevin dynamics equilibration period at 300 K,
during which the solute atom positions were fixed. The entire
binding site was then subjected to minimisation by SD to allow the
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solute to adjust to the solvent for 2000 steps with heavy atoms
fixed, for 5000 steps with main chain atoms fixed and then 10000
steps with no atom positions fixed. This was followed by a 10 ps
Langevin dynamics equilibration period when the temperature
was raised from 240 K to 300 K. Finally, the entire binding site
was equilibrated at 300 K for 50 ps. We ensured that the system
was brought to equilibrium before beginning the MD simulation
by verifying that the system reached a point where the energy
fluctuations were stable. Production simulations were then
performed for 10.0 ns at 300 K.
During all CHARMM dynamics simulation, the positions of
the main-chain heavy atoms were restrained using a 5.0 kcal/
mol/A˚2 harmonic force and the positions of the sidechain heavy
atoms were restrained using a 1.0 kcal/mol/A˚2 harmonic force.
The MD simulations were performed using the CHARMM
(version 34b1) program [27] with the CHARMM22 force field
[28] and using the SHAKE [31] algorithm to constrain the bonds
to hydrogen, allowing an MD time step of 1.0fs. The simulations
were performed using a deformable boundary potential with a
Langevin friction coefficient of 62.0 ps21 applied to the water
molecule oxygen atoms [32]. Electrostatic interactions were
modelled with a uniform dielectric and a dielectric constant of 1.0
throughout the setup and production runs. This protocol has
been used previously to analyse the dynamics of water molecules
in the HSP90 system [33]. To explore the dynamics in the
unbound state, simulations were performed on the peptide and
phosphopeptide structures alone. In these cases the protein was
deleted before preparing the system and the equilibration
procedure in Figure 2 was employed.
MM-PBSA Calculations
For the MM-PBSA calculations, we calculated the difference in
free energy between the protein-ligand complex and the unbound
protein plus the unbound ligand. MM-PBSA calculations were
performed at intervals of 10 ps from each 10.0 ns run to yield
1000 snapshots. All of the water molecules were deleted and so not
included explicitly in any of the MM-PBSA terms. For the
electrostatics interactions a dielectric constant of 2.0 was
Figure 2. A schematic representation of the equilibration procedure. A schematic representation of the equilibration procedure used to
prepare the systems for the MD simulations. The five systems that were simulated are highlighted in bold.
doi:10.1371/journal.pcbi.1000880.g002
Computational Analysis of PLK1
PLoS Computational Biology | www.ploscompbiol.org 4 August 2010 | Volume 6 | Issue 8 | e1000880
employed, as this reflects the dielectric constant within the protein
interior. The free energy change upon binding was calculated
using the following equation:
DGbind~Gcomplex{Gprotein{Gligand
~EMMzDGPBzDGSA{TDS
~EvdwzEeleczDEdeformationzDGPBzDGSA{TDS
ð1Þ
EMM is the molecular mechanics (MM) interaction energy between
the receptor and the ligand, DGPB and DGSA are the electrostatic and
non-polar contributions to desolvation upon ligand binding,
respectively, and 2TDS is the conformational entropy change, Evdw
is the van der Waals interaction energy, Eelec is the electrostatic
interaction energy and DEdeformation is the difference in internal energy
between the bound state ligand and the unbound state ligand. This is
termed the ligand deformation penalty. To calculate the ligand
deformation penalty, we ran two separate MD simulations of the
unbound ligands. MM-PBSA calculations were performed at
intervals of 10 ps from each 2.0 ns run to yield 200 snapshots. The
MM energies (DEMM) were calculated in CHARMM [27] for each
snapshot. The deformation penalty of the ligand was considered by
considering the MM energy of the peptide in both the bound state
and unbound state simulations. This comprised electrostatic, van der
Waals, and torsional contributions. We did not include the
deformation penalty of the protein, as this involves taking the
difference between the two large values of the protein internal energy.
Even small errors in the individual energetic terms of these absolute
internal energies can have a large impact on the relatively small
energy differences and thus introduce large errors to the predicted
binding energy [39]. The solvent accessible surface area (SASA)
calculations were performed using CHARMM by calculating the
change in surface area upon binding in A˚2 multiplied by a constant
value of 0.00542 kcal/mol plus the constant value of 0.92 kcal/mol.
To determine the key interactions between the phosphopeptide
and the protein, we also calculated the per-residue contribution to
the binding free energy for the phosphopeptide. Only sidechain
atom contributions were included for each residue and the
contributions from the mainchain atoms were calculated sepa-
rately. The intramolecular interaction energies between each pair
of residues was split in half and assigned evenly between the two
residues. The Poisson-Boltzmann (PB) desolvation penalties were
calculated with only the specific residue being considered. All
other ligand atoms were deleted. As the desolvation is not pairwise
additive, the sum of each desolvation piece differs to the total
calculated with the complete ligand. The SASA terms were
calculated for each residue without the SASA constant term. For
all simulations, we also considered the standard error of the mean
by dividing the simulation into 20 blocks of equal time and
calculating the standard deviation of the individual components of
the binding free energy.
Poisson-Boltzmann Calculations
The PB calculations to determine DGPB were performed using a
modified version of the DelPhi program [34–35] at a
12961296129 grid resolution with focusing boundary conditions
[36]. The molecular surface was used to represent the dielectric
boundary, a dielectric constant of 2.0 was used for the molecular
interior and a dielectric constant of 80.0 was used in the solvent
region. An ionic strength of 0.145 M with a Stern layer of 2.0 A˚
was used for all PB calculations. For each snapshot, separate
calculations were performed for the complex, the unbound protein
and the unbound peptide. Protein atoms were assigned PARSE
charges [37] before the DelPhi calculations. The DGPB for the
Poisson-Boltzmann portion of the free energy changes were then
calculated with the following equation:
DGPB~GPB complexð Þ{GPB proteinð Þ{GPB peptideð Þ ð2Þ
Gpb(complex), Gpb(protein) and Gpb(peptide) are the PB solvation
energies of the complex, the protein and the peptide respectively.
Vibrational Entropy Changes
An estimate of the vibrational entropy change upon binding was
performed, using normal mode analysis of the heavy atom
fluctuations [38]. We only included the entropy change for the
ligand, as simulation did not include the entire protein. Separate
calculations were performed for the bound ligands and the
unbound ligands and quasiharmonic analysis was used to estimate
the vibrational entropies of the bound and unbound states. The
VIBRAN module of the CHARMM program [27] was used to
determine normal modes and normal-mode frequencies by
diagonalisation of the force constant matrices. We used the entire
10.0 ns trajectories with a 20.0 fs timestep for the calculations.
Water molecules were not included in this analysis. Translational
and rotational motions were projected out from the dynamics
trajectories by reorienting all the species using mass weighting.
The frequencies of the vibrational modes for the heavy atoms were
then computed at 298 K using a quasiharmonic approximation.
The vibrational entropy of each system was then estimated from
the vibrational frequencies [38].
Static Binding Energy Calculations
Further binding energy calculations were performed on a static
structure as a comparison. We began with the prepared
phosphopeptide and peptide complexes. To adjust the complexes
for use with CHARMM [27], the crystal structures were first
subjected to a geometry optimization with the CHARMM22
energy function [28]. All receptor sidechains were harmonically
restrained with a force constant of 1.0 kcal/mol/A˚2 and all
receptor backbone atoms were fixed. The minimization was
performed for 1,000,000 steps using the adopted basis Newton-
Raphson method. All water molecules were then deleted and the
van der Waals, electrostatic and SASA terms were then calculated
with CHARMM. To calculate the ligand deformation, the ligand
structure was subjected to geometry optimization, separated from
the receptor, for 1,000,000 steps. It was necessary to place
harmonic restraints with a force constant of 1.0 kcal/mol/A˚2 on
all atoms to prevent the ligands from collapsing. The desolvation
calculations were then performed using DelPhi [34–35] as
described above. This can be considered a single-point MM-
PBSA calculation.
Energetics of Water Molecules at the Protein Surface
We performed additional analysis of the water molecules in the
CHARMM MD simulations. Initially, we calculated the mean
enthalpy of water molecules at specific sites at the binding
interface. For each site, we analysed 1000 snapshots at 10.0 ps
intervals across the 10.0 ns CHARMM simulation of the apo
protein. For each snapshot, we considered every water molecule
within 1.4 A˚ of each point and summed the MM energy. This
allowed us to derive the mean value of the enthalpy for water
molecules around each site. The relative energy with respect to
bulk water was calculated by subtracting the mean enthalpy of a
bulk water molecule. This was calculated using the MM energy
from an MD simulation of a box of water molecules. We
Computational Analysis of PLK1
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performed a 2.0ns simulation of a sphere of water molecules with
16s/20s reaction region/buffer region for stochastic boundary
MD. To exclude water molecules at the surface of the sphere, only
water molecules within 12.0 A˚ of the centre of the 20.0 A˚ sphere
were included in the calculations. The mean value of the enthalpy
of a bulk water molecule was calculated using 200 snapshots and
found to be 218.5 kcal/mol. However, such an analysis only
considers the enthalpic contribution to the free energy, ignoring
the solvent entropy. We thus performed further calculations to
explore the solvent enthalpy and entropy across the entire binding
interface. There are a number of methods used to include the
effects of solvent entropy on the free energy of water molecules.
These include free-energy perturbation [39–40], thermodynamic
integration [41] and inhomogeneous fluid solvation theory [42].
We chose to employ inhomogeneous fluid solvation theory, first
described by Lazaridis [42] and implemented in Schro¨dinger’s
WaterMap software [43–45]. In this method, molecular dynamics
simulations are analysed to cluster distinct hydration sites and
assign an enthalpy and entropy to each one. The enthalpy is
calculated as the average interaction energy over the simulation.
The entropy is calculated by comparing the distributions of
translations and orientations available to the water molecule in
bulk water and at the surface.
We performed calculations on the apo state and the
phosphopeptide complex. The WaterMap MD simulations were
run with Desmond [46] using the OPLS_2005 force field [47]. We
began with the prepared phosphopeptide complex and the apo
protein. All water molecules from the crystal structure were
deleted and TIP4P water molecules [48] were added with the
System Builder module in Maestro. The solvated structure was
then subjected to restrained minimisation using a force constant of
5.0 kcal/mol/A˚2 on the solute heavy atoms. This was followed by
a molecular dynamics simulation of 48.0 ps in which the
temperature of the system was increased from 10 to 300 K. The
harmonic restraints of 5.0 kcal/mol/A˚2 on solute heavy atoms
were retained. A preproduction simulation was then run at 300 K
for 120.0 ps. Finally, the production simulations were run for
2.0 ns in the NPT ensemble at a temperature of 300 K and a
pressure of 1 atm. The statistical analysis was performed using
snapshots from the production simulation. Water molecules in the
proximity of the binding site from 2000 equally spaced snapshots
were clustered to form hydration sites. For each hydration site, the
enthalpy was computed as the average non-bonded energy of each
water molecule within the hydration site with the rest of the
system. The excess entropy was computed by numerically
integrating a local expansion of spatial and orientational
correlation functions [44]. Only contributions from the first-order
term of the expansion were included.
At this stage, we have not incorporated the effect of the solvent
free energy on predictions of the total binding free energy of the
phosphopeptide. A complete treatment of the energetics of the
solvent would involve a consideration of all water molecules in
the complex and the apo protein. It would also require a
consideration of the unbound ligand. However, no prediction of
the binding free energy is complete without such consideration.
Protein surfaces can generate highly hydrophobic regions and this
creates volumes of space where water molecules have unfavorable
free energies. Filling these volumes with hydrophobic ligand
atoms is a general mechanism to increase the ligand binding
affinity. In some cases, there is a suggestion that water molecules
will completely evacuate extremely hydrophobic cavities [43].
The creation of a small vacuum region leads to a large energetic
penalty and filling such a cavity with a small molecule should
greatly increase its affinity.
Experimental Validation
To test the predictions made by the MM-PBSA calculations, the
affinities of the CDC25c peptide and phosphopeptide were
measured experimentally by fluorescence polarization (FP) [49]
and by isothermal titration calorimetry (ITC). Human PLK1
amino acids 345 to 603 were amplified by PCR and cloned into
the EcoRI and NotI sites of the bacterial expression vector
pGEX6P-1, expressed in E. Coli and purified as previously
described [12]. All peptides and phosphopeptides were synthesised
using standard chemistry (Designer Bioscience Ltd., Cambridge,
UK). The fluorescently labelled probe was the phosphopeptide
sequence MAGPMQSpTPLNGAKK with N-terminal TAMRA.
The peptide competitor was the sequence LLCSTPNGL and the
phosphopeptide competitor was the sequence LLCSpTPNGL. FP
measurements were carried out in a 384-well, low-volume, black,
flat bottom polystyrene NBS microplate (Corning 3820) using a
PHERAstar Plus plate reader (BMGLabtech). The final reaction
volume of 45 ml contained 10nM labelled probe peptide, 35nM
PBD and varying concentrations of competitor. FP values were
obtained in millipolarisation units at an excitation wavelength of
540 nm and an emission wavelength of 590 nm, and were
calculated in terms of percentage inhibitions. ITC measurements
were performed using a VP-ITC microcalorimeter (MicroCal
Inc.). The experiments consisted of injecting CDC25c peptide or
CDC25c phosphopeptide at a concentration of 120 mM into a
sample cell containing 12 mM of PBD in 50mM Hepes pH 7.4,
200mM NaCl, 1 mM EDTA, 1mM EGTA. Fifty injection of
4.5 ml of LLCSpTPNGL were performed with a spacing of 180 s
using a reference power of 25mCal/s. Thirty injections of 8 ml of
LLCSTPNGL were performed with a spacing of 240 s using
reference power of 25mCal/s. All binding isotherms were analysed
and graphed using Origin Software 7.5 (MicroCal Inc.).
Results
Once the MD simulations were complete, they were subjected to a
thorough analysis. The entire 10.0 ns of each trajectory was included
in the analysis, as the systems had been pre-equilibrated. This was
verified by two calculations. We calculated a time series of the root
mean square fluctuation (RMSF) of the protein alpha carbon atoms.
This value is stable over 10 ns for the apo protein, the peptide
complex and the phosphopeptide complex (Figure S1). We also
calculated a time series of the energetic components of the MM-
PBSA binding free energy for the peptide complex and the
phosphopeptide complex. The values are stable over 10 ns (Figures
S2 and S3). For each trajectory, we considered the predicted free
energy of binding for the peptide and the phosphopeptide, as well as
the free energy of water molecules at the surface.
MM-PBSA Calculations
The first calculation we performed was the prediction of the
MM-PBSA binding free energy change for both the peptide and
the phosphopeptide. The predicted binding free energy changes
calculated by this method are presented in Table 1. The CDC25c
phosphopeptide is predicted to bind with greater affinity than the
corresponding peptide due to the more favourable binding
enthalpy. As expected, the entropy changes of both ligands are
unfavourable, due to the restriction on the ligand poses in the
bound state. The calculations performed on the static structure are
also presented in Table 1. Both the enthalpy and the change in
enthalpy from the static calculations are similar to those predicted
by the dynamic MM-PBSA calculations. This suggests that for this
system, static calculations may be sufficient to predict relative
binding enthalpies. However, such static calculations ignore the
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change in both the solute and the solvent entropy that we aimed to
quantify with the MD simulations. To estimate the importance of
each residue in the phosphopeptide, we analysed the per-residue
contributions to the MM-PBSA binding enthalpy. The results are
presented in Table 2. They highlight the importance of the
phosphothreonine residue, which contributes over 30% of the
binding enthalpy of the phosphopeptide. In fact, the phospho-
threonine residue and the mainchain atoms together contribute
over 75% of the binding enthalpy of the phosphopeptide. This
begins to explains why the PBD does not discriminate strongly
between different phosphopeptides, as in this case only a small
contribution to the binding enthalpy is made by the non-
phosphothreonine sidechains. The residue Leu1 makes a reason-
able contribution to binding due to its strong van der Waals
interactions with a hydrophobic surface. This is consistent with the
experimental data from oriented peptide library screening, as
leucine is one of the residues selected for at the 24 position
[10,14]. Residues Cys3 and Asn7 are predicted to make a small
unfavourable contribution to binding. This is also consistent with
the experimental data, as these residues are not selected at the 22
and +2 positions. However, residues Leu2 and Ser4 are predicted
to make very little contribution to the binding enthalpy, but are
selected at positions 23 and 21 respectively [9–10]. The
importance of these residues is revealed by considering the
interactions of the solvent in the later sections.
Experimental Validation
The MM-PBSA calculations predict that the CDC25c phos-
phopeptide will bind to the PBD with higher affinity than the
CDC25c peptide. We tested this prediction experimentally using
an FP assay and by ITC. We measured the effect of both the
peptide and the phosphopeptide on binding of a fluorescently
Table 1. Predicted binding free energy change for the CDC25c phosphopeptide and peptide from dynamic and static structure
calculations.
CDC25c Phosphopeptide
(MMPBSA)
CDC25c Peptide
(MMPBSA)
CDC25c Phosphopeptide
(Static)
CDC25c Peptide
(Static)
VDW (kcal/mol) 241.361.2 236.060.8 256.0 253.0
Electrostatic Interaction (kcal/mol) 2187.563.4 225.661.2 2241.0 272.6
Desolvation Penalty (kcal/mol) 208.362.6 50.361.7 252.4 87.7
SASA(kcal/mol) 22.860.0 22.760.0 25.6 25.1
Ligand Deformation (kcal/mol) 29.3 27.9 5.9 10.1
DH (kcal/mol) 232.7 221.9 244.2 232.9
DDH (kcal/mol) 10.8 11.3
Unbound Peptide TS (kcal/mol) 71.861.1 62.561.0 NA NA
Bound Peptide TS (kcal/mol) 58.160.7 53.361.1 NA NA
2TDS Peptide (kcal/mol) 13.7 9.2 NA NA
2DTDS Peptide (kcal/mol) 24.5 NA
DG (kcal/mol) 219.0 212.7 NA NA
DDG (kcal/mol) 6.2 NA
The predicted binding free energy change for the CDC25c phosphopeptide and the CDC25c peptide from the MM-PBSA and static structure calculations. The separate
contributions to the binding free energy change are also reported. The ligand deformation is the difference between the internal energy of the ligand in the bound and
the unbound states. The entropic contribution to the binding free energy from the peptide is the difference between the entropy in the bound and unbound states
calculated by normal mode analysis. The standard errors of the mean are estimated from twenty equally sized blocks.
doi:10.1371/journal.pcbi.1000880.t001
Table 2. Per-residue contributions to the predicted MM-PBSA binding free energy change for the CDC25c phosphopeptide (kcal/
mol).
Residue VDW Interaction Electrostatic Interaction Ligand Deformation Desolvation SASA Total Percent Total
Mainchain 220.560.4 222.361.0 22.3 37.161.1 21.960.0 29.7 42.5
Leu 1 (24) 24.360.4 0.160.0 21.0 1.560.1 20.260.0 24.0 17.3
Leu 2 (23) 22.860.3 0.260.0 20.8 3.160.3 20.260.0 20.5 2.3
Cys 3 (22) 20.560.5 0.160.1 20.9 2.760.1 20.260.0 1.2 25.1
Ser 4 (21) 24.260.4 060.4 22.5 6.560.3 20.160.0 20.3 1.5
pThr 5 (0) 22.561.0 2162.063.7 20.7 157.862.6 20.460.0 27.8 34.1
Pro 6 (+1) 22.060.1 3.160.1 21.8 21.360.1 0.060.0 21.9 8.4
Asn 7 (+2) 24.560.2 26.760.2 0.6 11.060.2 20.160.0 0.2 21.0
Totals 241.361.2 2187.563.4 29.3 218.362.6 23.160.0 222.9 100.0
The predicted MM-PBSA binding free energy change for the CDC25c phosphopeptide, split into per-residue contributions, and the percentage of each contribution to
the total binding free energy. The standard errors of the mean are estimated from twenty equally sized blocks.
doi:10.1371/journal.pcbi.1000880.t002
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tagged phosphopeptide. The FP results can be seen in Figure 3
and show that, as predicted, the CDC25c phosphopeptide has a
significantly higher affinity than the CDC25c peptide, which
showed no measurable binding. We also measured the binding of
the CDC25c peptide and the CDC25c phosphopeptide by ITC.
The ITC data can be seen in Figure 4 and confirms that the
CDC25c peptide shows no detectable binding and the CDC25c
phosphopeptide binds with a measured affinity of 0.705 mM.
These results are consistent with the biological function of PLK1
and with prior experimental work on other phosphopeptides, but
have not previously been explained quantitatively.
Interfacial Water Molecules
In order to understand the dynamic nature of the system, we
looked at the trajectory of each individual water molecule in each
simulation and calculated the RMSF of the oxygen atom from its
mean position. The water molecules in the sphere of water molecules
are highly mobile, with a mean RMSF of 11.5 A˚. No water molecule
has an RMSF below 2.0 A˚. However, in all three protein simulations
there are a large number of water molecules near the protein surface
with an RMSF below 0.5 A˚. It is clear that even in the apo state,
water molecules are fixed to some degree at the surface. It is possible
that a larger sphere of water molecules or a longer timescale is needed
to accurately model the mobility of these surface water molecules.
However, the conclusion is supported by analysis of the water
molecules in the apo crystal structures, which have B factors similar to
the protein residues. A closer examination of individual water
molecules across the simulation reveals the presence of distinct
hydration sites at the surface, formed by hydrogen bonding
interactions with the protein. Figure 5a shows four such hydration
sites, occupied by one water molecule during the course of the 10.0ns
simulation of the apo protein. Water molecules at the circled site form
a hydrogen bond to the backbone amide of residue Trp414. Water
molecules in this hydration site are expelled upon ligand binding and
replaced by the serine residue at the 22 position of the consensus
sequence. We estimated the enthalpy of water molecules at this site
with respect to bulk water for each of the 1000 snapshots of the apo
protein. We placed the hydration site at a position 3.0 A˚ along the
amide nitrogen to amide hydrogen bond vector. For each snapshot,
we considered every water molecule within 1.4 A˚ of the site,
representing the idealized radius of a water molecule. There is a water
molecule within this sphere in 99% of snapshots, whilst the average
enthalpy of water molecules within the sites with respect to bulk water
is +1.361.5 kcal/mol. Expulsion of water molecules from this site
should thus provide an enthalpic bonus upon ligand binding.
However, water molecules at the circled hydration site show marked
translational and orientational ordering, as shown in Figures 5b. This
corresponds to an unfavourable entropy with respect to bulk water
Figure 3. The results of CDC25c peptide and CDC25c phosphopeptide binding to the PBD by FP. The effect of unlabelled CDC25c
peptide and CDC25c phosphopeptide on the binding of the PBD to the TAMRA labelled consensus phosphopeptide sequence in the FP Assay. The
phosphopeptide or peptide concentrations are reported on the x axis and the percentage inhibitions are reported on the y axis. The inhibition curves
are coloured blue for the phosphopeptide and red for the peptide.
doi:10.1371/journal.pcbi.1000880.g003
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and should lead to an entropic bonus to ligand binding upon
expulsion of a water from this hydration site. We thus employed
inhomogeneous fluid solvation theory, implemented in Schrodinger’s
WaterMap, to explore the enthalpy and entropy of water molecules
at this surface.
Free Energy Calculations
Analysis of the WaterMap results highlights a number of
important points. Eleven hydration sites from the apo protein that
overlap with the phosphopeptide sidechains are shown in Figure 6.
Details of the enthalpy and entropy of the hydration sites are given
in Table 3. It is clear that phosphopeptide binding expels a
number of unsatisfied water molecules from hydration sites on the
surface of the PBD, including the site I, which was identified by the
CHARMM simulation. Water molecules in these hydration sites
do not make their full complement of four hydrogen bonds, the
majority have an unfavourable enthalpy with respect to bulk water
and all eleven have an unfavourable entropy. The WaterMap
calculations suggest that a water molecule at hydration site I is
particularly unfavourable with respect to bulk water and
displacement by phosphopeptide binding is predicted to yield
3.56 kcal/mol in binding free energy. This explains the impor-
tance of serine at the 21 position in this sequence. Large residues
are unable to fit in this small hydrophobic cavity and the smaller
residues glycine or alanine would not displace a water molecule
from this site. In fact, they would likely further destabilize it due to
desolvation. In fact, expulsion of surface water molecules is
predicted to yield over 3.0 kcal/mol for each of the residues Leu1,
Leu2, Cys3, Ser4 and Asn7 as shown in Table 3. The total
contribution to the binding free energy of expelling all eleven
water molecules is predicted to be 20.26 kcal/mol. 13.85 kcal/mol
of this is derived from a favorable change in the solvent entropy.
This is of great significance, as the binding free energy from the
MM-PBSA calculation is only 219.0 kcal/mol. It is also
significant, as it explains the requirement for hydrophobic residues
at the 24, 23 and +2 positions. Any large residue at one of these
positions can extend across the protein surface and displace
ordered water molecules, yielding an entropic bonus to the
Figure 4. The results of CDC25c peptide and CDC25c phosphopeptide binding to the PBD by ITC. ITC data for the binding of CDC25c
peptide and CDC25c phosphopeptide to the PBD of PLK1. The ITC traces and the determined thermodynamic parameters of binding are shown. The
CDC25c peptide displays no detectable binding. The binding of the CDC25c phosphopeptide can be fit to a Kd of 0.705 mM. Errors in thermodynamic
parameters are derived from the fitting error after repeating the experiment at least three times.
doi:10.1371/journal.pcbi.1000880.g004
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binding free energy. The consensus phosphopeptide for the PLK1
PBD thus contains a number of non-specific hydrophobic residues.
It is interesting to note that the N-terminal proline residues of the
optimal synthetic phosphopeptide PMQSpTPL [10] and the high-
affinity short phosphopeptide PLHSpT [14] both overlap with
hydration sites D, E and F as well as further unfavourable
hydration sites (data not shown).
The second role of water molecules at this interface is more subtle.
In the complex, the presence of the charged phosphate group greatly
affects water molecules in the seven hydration sites shown in Figure 7.
Water molecules f and g are expelled upon ligand binding and this is
predicted to have a net unfavourable contribution to binding, as
detailed in Table 4. However, water molecules a, b, c, d, and e are all
present in the apo and the bound states. These five water molecules
are also observed in the crystal structure of 3BZI with low B factors.
The positions from the crystal structure of the complex are also shown
in Figure 7 and are very close to the predicted hydration site, which
are coloured red. The five water molecules are pre-ordered in the apo
state, with an unfavourable entropy with respect to bulk water, but
are pre-ordered in the correct geometry to coordinate the phosphate.
Thus, whilst phosphopeptide binding further orders these water
molecules, it also provides them with a huge enthalpic bonus, as
shown in Table 4. In fact, stabilizing these five water molecules is
predicted to yield 217.86 kcal/mol. Thus, stabilization provides a
greater free energy bonus than displacement, which would only yield
211.71 kcal/mol. This effect of stabilizing ordered water molecules
has not previously been quantified and these results suggest that this
can represent a significant component of binding free energies.
Discussion
Our simulations make a number of predictions. The first is that
the CDC25c phosphopeptide will bind to the PBD with higher
affinity than the unmodified CDC25c peptide. This prediction was
confirmed by the results of the FP and ITC experiments, in which
the phosphopeptide was found to bind strongly with a Kd of
0.705 mM but the peptide showed no detectable binding. It is also
consistent with the biological understanding of PLK1, which binds
phosphopeptides in vivo, and agrees with recent work showing
that the phosphopeptide LHSpTAI binds to the PBD of PLK1
with a Kd of 0.247 mM but the peptide LHSTAI shows no
detectable binding [14]. The per-residue contributions to the
enthalpy predict that the main determinants of binding are the
mainchain hydrogen bonding interactions and the negatively
charged phosphate group interacting with the electropositive bath
of water molecules around His538 and Lys540. This is illustrated
by the contribution of over 75% to the binding enthalpy made by
the mainchain atoms and the phosphothreonine residue alone.
The sidechains of residues at the 23, 22, 21, +1 and +2 positions
are predicted to make only a small contribution to the binding
enthalpy. This explains why peptides do not bind and also explains
the lack of selectivity, with many diverse phosphopeptide
sequences binding. It is important to note that the per residue
predictions will only correspond to the biological importance of
these residues if the phosphopeptide adopts the same orientation
as the phosphoprotein it represents. Specifically, residues at the
24 and 23 positions appear able to adopt very different
orientations in different phosphopeptides whereas this may not
be true for the corresponding phosphoproteins due to secondary
structure constraints.
However, the simulations also highlight the importance of water
molecules at this interface, which MM-PBSA calculations do not
explicitly consider. As noted in the introduction, bridging water
molecules appear to be very important in mediating interactions
between the PBD and its target phosphopeptides. Initial analysis
with CHARMM identifies distinct hydration sites on the protein
surface and predicts water molecules are enthalpically unfavour-
able with respect to bulk water. Visual inspection suggests that
Figure 5. Snapshots of water molecules during the 10.0ns simulation. Translational and orientational ordering of water molecules at specific
sites during the 10.0ns simulation. (a) 1000 snapshots of the oxygen atom for one water molecule, illustrating the presence of distinct hydration
sights. PBD residues Lys 413, Trp414 and Leu 490 are displayed as atom coloured sticks and labelled. (b) Snapshots of any water molecule
coordinating to the backbone amide of Trp414 during the simulation, illustrating the restricted rotational freedom of water molecules at this position.
PBD residue Trp414 is displayed as atom coloured balls and sticks and labeled.
doi:10.1371/journal.pcbi.1000880.g005
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Figure 6. An overlay of the CDC25c phosphopeptide on a subset of the hydration sites from a simulation of the apo state. A subset
of the hydration sites identified by WaterMap from the apo state simulation that overlap with the phosphopeptide. Hydration sites are displayed as
cyan balls and labeled with letters A–K. The overlayed phosphopeptide is displayed as atom colored balls and sticks with a molecular surface in white.
Residues Leu1, Leu2, Cys3, Ser4 and Asn7 are labeled. PBD binding site residues are displayed in atom coloured CPK.
doi:10.1371/journal.pcbi.1000880.g006
Table 3. Energetic analysis of hydration sites where a water molecule is displaced by CDC25c phosphopeptide binding.
Residue Site Occupancy Mean HBs DH 2TDS DG ResidueDH Residue 2TDS ResidueDG
Leu 1 A 0.30 2.60 1.57 0.85 2.42
Leu 1 B 0.30 3.18 20.05 0.85 0.80
Leu 1 C 0.28 3.02 1.22 0.73 1.95 2.74 2.43 5.17
Leu 2 D 0.29 3.60 0.31 0.81 1.12
Leu 2 E 0.73 2.76 22.50 2.46 20.04
Leu 2 F 0.36 3.06 1.50 1.03 2.53 20.69 4.30 3.61
Cys 3 G 0.33 3.06 2.01 0.85 2.86
Cys 3 H 0.58 2.64 20.58 1.73 1.15 1.43 2.58 4.01
Ser 4 I 0.84 2.20 0.80 2.76 3.56 0.80 2.76 3.56
Asn 7 J 0.32 2.99 1.22 0.86 2.08
Asn 7 K 0.32 3.04 0.91 0.92 1.83 2.13 1.78 3.91
Total 6.41 13.85 20.26
Details of eleven hydration sites from the apo protein surface that overlap with sidechains of the bound phosphopeptide. The occupancy, mean number of hydrogen
bonds (Mean HBs), change in enthalpy, entropy and free energy are relative to bulk water. The sites are labelled A–K and are displayed in Figure 6. The enthalpy,
entropy and free energy are weighted by the occupancy of the site.
doi:10.1371/journal.pcbi.1000880.t003
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there is significant ordering of these water molecules and thus that
there will be a change in solvent entropy upon ligand binding. We
thus employed inhomogeneous fluid solvation theory to consider
solvent enthalpy and entropy. It is important to note that small
inaccuracies in calculations of free energies for individual water
molecules will cause major inaccuracies in overall predictions, as
there may be a large number of interfacial water molecules and
any errors are multiplied. However, in cases where there are a
large number of interfacial water molecules, such calculations are
very important and may dominate the free energies calculated by
MM-PBSA or MM-GBSA methods. The overall contribution of
the solvent free energy change should be termed the hydric effect
Figure 7. Hydration sites surrounding the phosphate group in the apo state and the phosphopeptide complex. Hydration sites
identified by WaterMap that surround the phosphate group. The hydration sites from the apo state simulation are displayed as cyan balls and labeled
a-m. The hydration sites from the complex simulation are displayed as pink balls and labeled a9–e9. The phosphopeptide and five water molecule from
the crystal structure are displayed as atom colored balls and sticks. PBD binding site residues Trp414 and Lys540 are displayed in atom coloured CPK
and labelled.
doi:10.1371/journal.pcbi.1000880.g007
Table 4. Energetic analysis of hydration sites where a water molecule is stabilized by CDC25c phosphopeptide binding.
Site
Occupancy Apo/
Bound DH Apo DH Bound 2TDS Apo 2TDS Bound DG Apo DG Bound DDH Bind DTDS Bind DDG Bind
a 0.86/1.00 21.13 27.80 2.94 5.11 1.81 22.69 26.67 2.17 24.50
b 0.45/1.00 1.14 25.10 1.33 4.41 2.47 20.69 26.24 3.08 23.16
c 0.96/1.00 21.52 29.89 3.39 5.66 1.87 24.23 28.37 2.27 26.10
d 0.92/1.00 0.65 23.07 3.63 5.58 4.28 2.51 23.72 1.95 21.77
e 0.42/0.99 0.11 24.91 1.17 3.30 1.28 20.51 25.02 2.13 21.79
f 0.42/0.00 20.95 NA 1.29 NA 0.34 NA 0.95 21.29 20.34
m 0.60/0.00 22.62 NA 1.82 NA 20.80 NA 2.62 21.82 0.80
Sum 11.25 25.61 226.45 8.49 216.86
Details of seven hydration sites from the apo protein surface in the proximity of the phosphate group. The occupancy, change in enthalpy, entropy and free energy are
relative to bulk water. The changes in the energy changes upon binding are the difference between the apo and the bound states. The sites are labelled a-m and are
displayed in Figure 7. The enthalpy, entropy and free energy are weighted by the occupancy of the site.
doi:10.1371/journal.pcbi.1000880.t004
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and not the hydrophobic effect, because displacement of some
water molecules contributes positively to binding and displacement
of others contributes negatively to binding.
The WaterMap analysis of hydration sites on the surface of the
PBD predicts that water molecules have two distinct effects on the
binding in this system. Firstly, ligand binding expels water
molecules from hydration sites that are both enthalpically and
entropically unfavourable with respect to bulk water. In particular,
the key Ser4 residue from the phosphopeptide displaces a highly
unfavourable water molecule in a hydrophobic cavity and this
explains its importance. At other positions in the sequence,
expulsion of water molecules from hydration sites on the
hydrophobic surface provides a bonus to the binding free energy
that is non-specific, as any large residue would have a similar
effect. The promiscuous binding of the PBD due to elimination of
ordered water molecules from the surface is consistent with
suggestions that the hydrophobic effect is a general mechanism to
provide affinity, but specificity must be achieved by electrostatic
complementarity. Such broad specificity for substrates is also
observed for the oligopeptide binding protein OppA and this
behaviour has been attributed to the presence of bridging water
molecules [50]. It would be interesting to study this system to
analyze the importance of water elimination and water stabiliza-
tion in providing a general mechanism for broad specificity.
However, water molecules are also found at sites with a much
narrower specificity such as the SRC SH2 domain [51] and the L-
arabinose-binding protein [52]. Interfacial water molecules are
thus able to elicit opposite effects of both broad and narrow
specificity [53–55]. This highlights the importance of explicitly
considering water molecules within each particular system. The
second predicted effect on the binding free energy is that the
phosphate group of the ligand strongly stabilizes a number of
water molecules that are highly ordered at the apo protein surface
but are enthalpically unfavorable. This stabilization is an effect
that has not previously been described and quantified and it will be
interesting to examine other systems to determine whether this is a
common phenomenon.
A WaterMap analysis performed on the PBD of PLK1
highlights hydration sites containing ordered water molecules
where ligand binding should lead to a favorable free energy
change. The binding conformations of a number of phospho-
peptides determined from the crystal structures overlay a
number of such hydrophobic sites and the hydrophobic effect
is likely to be one of the major determinants of binding in these
systems. In particular, the backbone amide and carbonyl groups
of Trp414 create two highly unfavourable hydration sites H and
I in Figure 6 that are trapped between the hydrophobic
sidechains of Trp414 and Leu490. Hydrophobically enclosed
correlated hydrogen bonds such as these have been identified
previously as a key determinant of binding [43]. Developing
small molecule inhibitors that specifically target these hydration
sites is likely to yield high-affinity binding for small molecule
inhibitors of the interaction between the phosphopeptide and
the PBD. The observation that PLK1 is over-expressed in
human cancer has led to the development of several PLK1
inhibitors targeting the ATPase activity for cancer therapy
[56–61]. However, the genetic inactivation of PLK1 can trigger
mitotic arrest and apoptosis in a range of cells and tissues
[62–63], raising the possibility that more subtle means to
interrupt abnormal PLK1 function may offer an improved
therapeutic window. A number of small molecule inhibitors of
the PBD of PLK1 have been reported to date [64–65].
Interestingly, molecular docking results on the molecule
purpurogallin [66] suggest that it binds in the phosphopeptide
binding groove and visual inspection suggests that binding
would displace the three highly unfavourable water molecules I,
a and c. In this light, our observations concerning the
recognition of phosphopeptide substrates by the PLK1 PBD
may open new perspectives for the design of inhibitors that
inhibit the activity of PLK1 towards specific substrates. Thus,
the analysis performed in this study is likely to be useful to drug
development efforts. It is important to note that affinity gain due
to displacement of unsatisfied water molecules would not be
modelled explicitly by traditional scoring functions because they
do not consider the apo state. The hydrophobic effect is known
to be a key determinant of binding and is one of the major
driving forces of binding. This is one of the major deficiencies in
current scoring functions, particularly when applied to protein-
protein interactions. An accurate treatment of the free energy of
interfacial water molecules would be a significant improvement
to current approaches and may prove crucial for accurately
predicting binding free energies at protein-protein interfaces. A
complete treatment will require an analysis of the unbound
states of the ligand and the protein as well as the bound
complex.
In conclusion, our results highlight the importance of water
molecules in the binding between CDC25c and the PLK1-PBD
and suggest that an explicit consideration of solvent is vital when
studying protein-protein interactions. The work presented here
adds to the growing literature showing that the free energy of
interfacial water molecules is different from the free energy of bulk
water molecules and that this can make a major contribution to
binding. Finally, our analysis identifies a number of sites where
small molecule inhibitors should gain affinity by displacing or
stabilizing highly ordered water molecules.
Supporting Information
Figure S1 Time series of the RMSF of the backbone alpha
carbons.
Found at: doi:10.1371/journal.pcbi.1000880.s001 (0.19 MB TIF)
Figure S2 Time series of the MM-PBSA energy components for
the phosphopeptide.
Found at: doi:10.1371/journal.pcbi.1000880.s002 (0.14 MB TIF)
Figure S3 Time series of the MM-PBSA energy components for
the peptide.
Found at: doi:10.1371/journal.pcbi.1000880.s003 (0.72 MB TIF)
Acknowledgments
The authors would like to thank Woody Sherman, Bruce Tidor, Bracken
King and Danny Cole for helpful discussions.
Author Contributions
Conceived and designed the experiments: DJH GHG. Performed the
experiments: DJH DDR AJN BH MRT. Analyzed the data: DJH DDR.
Contributed reagents/materials/analysis tools: DDR. Wrote the paper:
DJH GJM ARV MCP.
References
1. Barr FA, Sillje HH, Nigg EA (2004) Polo-like kinases and the orchestration of
cell division. Nat Rev Mol Cell Biol 5: 429–440.
2. Lowery DM, Lim D, Yaffe MB (2005) Structure and function of Polo-like
kinases. Oncogene 24: 248–259.
Computational Analysis of PLK1
PLoS Computational Biology | www.ploscompbiol.org 13 August 2010 | Volume 6 | Issue 8 | e1000880
3. Petronczki M, Lenart P, Peters JM (2008) Polo on the rise - from mitotic entry to
cytokinesis with Plk1. Dev Cell 14: 646–659.
4. Xie SQ, Xie B, Lee MY, Dai W (2005) Regulation of cell cycle checkpoints by
polo-like kinases. Oncogene 24: 277–286.
5. Strebhardt K, Ullrich A (2006) Targeting polo-like kinase 1 for cancer therapy.
Nat Rev Cancer 6: 321–330.
6. Watanabe N, Arai H, Nishihara Y, Taniguchi M, Watanabe N, et al. (2004) M-
phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by
SCF beta-TrCP. Proc Natl Acad Sci U S A 101: 4419–4424.
7. Toyoshima-Morimoto F, Taniguchi E, Shinya N, Iwamatsu A, Nishida E (2001)
Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during
prophase. Nature 410: 215–220.
8. Kumagai A, Dunphy WG (1996) Purification and molecular cloning of Plx1, a
Cdc25-regulatory kinase from Xenopus egg extracts. Science 273: 1377–1380.
9. Elia AEH, Cantley LC, Yaffe MB (2003) Proteomic screen finds pSer/pThr-
binding domain localizing Plk1 to mitotic substrates. Science 299: 1228–1231.
10. Elia AEH, Rellos P, Haire LF, Chao JW, Ivins FJ, et al. (2003) The molecular
basis for phosphodependent substrate targeting and regulation of Plks by the
Polo-box domain. Cell 115: 83–95.
11. Lowery DM, Clauser KR, Hjerrild M, Lim D, Alexander J, et al. (2007)
Proteomic screen defines the Polo-box domain interactome and identifies Rock2
as a Plk1 substrate. Embo J 26: 2262–2273.
12. Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN (2003) The crystal
structure of the human polo-like kinase-1 polo box domain and its phospho-
peptide complex. Embo J 22: 5757–5768.
13. Garcia-Alvarez B, de Carcer G, Ibanez S, Bragado-Nilsson E, Montoya G
(2007) Molecular and structural basis of polo-like kinase 1 substrate recognition:
Implications in centrosomal localization. Proc Natl Acad Sci U S A 104:
3107–3112.
14. Yun SM, Moulaei T, Lim D, Bang JK, Park JE, et al. (2009) Structural and
functional analyses of minimal phosphopeptides targeting the polo-box domain
of polo-like kinase 1. Nat Struct Mol Biol 16: 876–882.
15. Pawson T, Nash P (2003) Assembly of cell regulatory systems through protein
interaction domains. Science 300: 445–452.
16. Hanisch A, Wehner A, Nigg EA, Sillje HH (2006) Different Plk1 functions show
distinct dependencies on Polo-Box domain-mediated targeting. Mol Biol Cell 17:
448–459.
17. Wilker EW, Grant RA, Artim SC, Yaffe MB (2005) A structural basis for 14-3-
3sigma functional specificity. J Biol Chem 280: 18891–18898.
18. Huen MS, Grant R, Manke I, Minn K, Yu X, et al. (2007) RNF8 transduces the
DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.
Cell 131: 901–914.
19. Durocher D, Taylor IA, Sarbassova D, Haire LF, Westcott SL, et al. (2000) The
molecular basis of FHA Domain : Phosphopeptide binding specificity and
implications for phospho-dependent signaling mechanisms. Mol Cell 6:
1169–1182.
20. Karplus M, McCammon JA (2002) Molecular dynamics simulations of
biomolecules. Nat Struct Biol 9: 646–652.
21. Deng Y, Roux B (2009) Computations of standard binding free energies with
molecular dynamics simulations. J Phys Chem B 113: 2234–2246.
22. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, et al. (2000) Calculating
structures and free energies of complex molecules: combining molecular
mechanics and continuum models. Acc Chem Res 33: 889–897.
23. Fogolari F, Brigo A, Molinari H (2003) Protocol for MM/PBSA molecular
dynamics simulations of proteins. Biophys J 85: 159–166.
24. Wong S, Amaro RE, McCammon JA (2009) MM-PBSA Captures Key Role of
Intercalating Water Molecules at a Protein-Protein Interface. J Chem Theory
Comput 5: 422–429.
25. Hou T, Chen K, McLaughlin WA, Lu B, Wang W (2006) Computational
analysis and prediction of the binding motif and protein interacting partners of
the Abl SH3 domain. PLoS Comput Biol 2: e1.
26. Leroux V, Gresh N, Liu WQ, Garbay C, Maigret B (2007) Role of water
molecules for binding inhibitors in the SH2 domain of Grb2: A molecular
dynamics study. J Mol Struct -Theochem 806: 51–66.
27. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, et al. (1983)
Charmm - a Program for Macromolecular Energy, Minimization, and
Dynamics Calculations. J Comput Chem 4: 187–217.
28. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, et al. (1998)
All-atom empirical potential for molecular modeling and dynamics studies of
proteins. J Phys Chem B 102: 3586–3616.
29. Feller SE, MacKerell AD (2000) An improved empirical potential energy
function for molecular simulations of phospholipids. J Phys Chem B 104:
7510–7515.
30. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983)
Comparison of Simple Potential Functions for Simulating Liquid Water. J Chem
Phys 79: 926–935.
31. Ryckaert JP, C G, Berendsen HJC (1977) Numerical integration of the cartesian
equations of motion of a system with constraints: molecular dynamics of n-
alkanes. J Comput Phys 23: 327–341.
32. Brunger A, CL B, M K (1984) Stochastic boundary conditions for molecular
dynamics simulations of ST2 water. Chem Phys Lett 105: 495–500.
33. Yan A, Grant GH, Richards WG (2008) Dynamics of conserved waters in
human Hsp90: implications for drug design. J R Soc Interface 5 Suppl 3:
S199–205.
34. Gilson MK, Honig B (1988) Calculation of the Total Electrostatic Energy of a
Macromolecular System - Solvation Energies, Binding-Energies, and Confor-
mational-Analysis. Proteins-Structure Function and Genetics 4: 7–18.
35. Gilson MK, Sharp KA, Honig BH (1988) Calculating the Electrostatic Potential
of Molecules in Solution - Method and Error Assessment. J Comput Chem 9:
327–335.
36. Nicholls A, Honig B (1991) A rapid finite difference algorithm, utilizing
successive over-relaxation to solve the Poisson-Boltzmann equation. J Comput
Chem 12: 435–445.
37. Sitkoff D, Sharp KA, Honig B (1994) Accurate Calculation of Hydration Free-
Energies Using Macroscopic Solvent Models. J Phys Chem 98: 1978–1988.
38. Carrington BJ, Mancera RL (2004) Comparative estimation of vibrational
entropy changes in proteins through normal modes analysis. J Mol Graph Model
23: 167–174.
39. Li Z, Lazaridis T (2007) Water at biomolecular binding interfaces. Phys Chem
Chem Phys 9: 573–581.
40. Michel J, Tirado-Rives J, Jorgensen WL (2009) Prediction of the Water Content
in Protein Binding Sites. J Phys Chem B 113: 13337–13346.
41. Hamelberg D, McCammon JA (2004) Standard free energy of releasing a
localized water molecule from the binding pockets of proteins: double-
decoupling method. J Am Chem Soc 126: 7683–7689.
42. Lazaridis T (2000) Solvent reorganization energy and entropy in hydrophobic
hydration. J Phys Chem B 104: 4964–4979.
43. Young T, Abel R, Kim B, Berne BJ, Friesner RA (2007) Motifs for molecular
recognition exploiting hydrophobic enclosure in protein-ligand binding. Proc
Natl Acad Sci U S A 104: 808–813.
44. Abel R, Young T, Farid R, Berne BJ, Friesner RA (2008) Role of the active-site
solvent in the thermodynamics of factor Xa ligand binding. J Am Chem Soc 130:
2817–2831.
45. Beuming T, Farid R, Sherman W (2009) High-energy water sites determine
peptide binding affinity and specificity of PDZ domains. Protein Sci 18:
1609–1619.
46. D. E. Shaw Research NY, NY (USA). Desmond Molecular Dynamics System.
47. Jorgensen WL, Maxwell DS, TiradoRives J (1996) Development and testing of
the OPLS all-atom force field on conformational energetics and properties of
organic liquids. J Am Chem Soc 118: 11225–11236.
48. Jorgensen WL, Madura JD (1985) Temperature and Size Dependence for
Monte-Carlo Simulations of Tip4P Water. Mol Phys 56: 1381–1392.
49. Lynch BA, Loiacono KA, Tiong CL, Adams SE, MacNeil IA (1997) A
fluorescence polarization based Src-SH2 binding assay. Anal Biochem 247:
77–82.
50. Tame JRH, Sleigh SH, Wilkinson AJ, Ladbury JE (1996) The role of water in
sequence-independent ligand binding by an oligopeptide transporter protein.
Nat Struct Biol 3: 998–1001.
51. Bradshaw JM, Waksman G (1999) Calorimetric examination of high-affinity Src
SH2 domain-tyrosyl phosphopeptide binding: Dissection of the phosphopeptide
sequence specificity and coupling energetics. Biochemistry 38: 5147–5154.
52. Quiocho FA, Wilson DK, Vyas NK (1989) Substrate specificity and affinity of a
protein modulated by bound water molecules. Nature 340: 404–407.
53. Ladbury JE (1996) Just add water! The effect of water on the specificity of
protein-ligand binding sites and its potential application to drug design. Chem
Biol 3: 973–980.
54. Levy Y, Onuchic JN (2006) Water mediation in protein folding and molecular
recognition. Annu Rev Biophys Biomol Struct 35: 389–415.
55. Ball P (2008) Water as an active constituent in cell biology. Chem Rev 108:
74–108.
56. Stevenson CS, Capper EA, Roshak AK, Marquez B, Eichman C, et al. (2002)
The identification and characterization of the marine natural product
scytonemin as a novel antiproliferative pharmacophore. J Pharmacol Exp Ther
303: 858–866.
57. Liu Y, Shreder KR, Gai W, Corral S, Ferris DK, et al. (2005) Wortmannin, a
widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mamma-
lian polo-like kinase. Chem Biol 12: 99–107.
58. Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Baker SJ, et al. (2005)
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent
anticancer agent. Cancer Cell 7: 275–286.
59. McInnes C, Mazumdar A, Mezna M, Meades C, Midgley C, et al. (2006)
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat
Chem Biol 2: 608–617.
60. Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, et al. (2007) BI
2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth
in vivo. Curr Biol 17: 316–322.
61. Lansing TJ, McConnell RT, Duckett DR, Spehar GM, Knick VB, et al. (2007)
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase
1. Mol Cancer Ther 6: 450–459.
62. Liu X, Lei M, Erikson RL (2006) Normal cells, but not cancer cells, survive
severe Plk1 depletion. Mol Cell Biol 26: 2093–2108.
63. Liu X, Erikson RL (2003) Polo-like kinase (Plk)1 depletion induces apoptosis in
cancer cells. Proc Natl Acad Sci U S A 100: 5789–5794.
64. Reindl W, Yuan J, Kramer A, Strebhardt K, Berg T (2008) Inhibition of polo-
like kinase 1 by blocking polo-box domain-dependent protein-protein interac-
tions. Chem Biol 15: 459–466.
Computational Analysis of PLK1
PLoS Computational Biology | www.ploscompbiol.org 14 August 2010 | Volume 6 | Issue 8 | e1000880
65. Watanabe N, Sekine T, Takagi M, Iwasaki J, Imamoto N, et al. (2009)
Deficiency in chromosome congression by the inhibition of Plk1 polo box
domain-dependent recognition. J Biol Chem 284: 2344–2353.
66. Liao C, Park J-E, Bang JK, Nicklaus MC, Lee KS (2010) Probing Binding
Modes of Small Molecule Inhibitors to the Polo-Box Domain of Human Polo-
like Kinase 1. ACS Med Chem Lett 1: 110–114.
Computational Analysis of PLK1
PLoS Computational Biology | www.ploscompbiol.org 15 August 2010 | Volume 6 | Issue 8 | e1000880
